Answer: Statement E is INCORRECT
Hypothyroidism during pregnancy is NOT normal and REQUIRES treatment. This is the clearly incorrect statement among the options provided.
Detailed Analysis of Each Statement
Statement E - Pregnancy and Hypothyroidism (INCORRECT)
Overt untreated hypothyroidism during pregnancy causes serious maternal and fetal complications including spontaneous miscarriage, preterm delivery, preeclampsia, maternal hypertension, postpartum hemorrhage, low birth weight, stillbirth, and impaired intellectual and psychomotor development of the fetus 1.
The guidelines are unequivocal: pregnant women or women planning pregnancy who have elevated TSH should be treated with levothyroxine to restore TSH to the reference range 2. This recommendation is based on the association between high TSH and increased fetal wastage or neuropsychological complications in offspring 2. Even subclinical hypothyroidism in pregnancy warrants treatment given the potential benefit-risk ratio 2.
Statement A - Bacterial Pneumonia Susceptibility (CORRECT)
Hypothyroid patients do have increased susceptibility to infections, though they may not manifest fever as frequently. Research shows that despite comparable infection rates, hypothyroid patients less frequently manifested fever (35% versus 79%, p<0.001) compared to controls 3. This blunted febrile response can mask serious infections including bacterial pneumonia.
Statement B - Psychiatric Manifestations (CORRECT)
Psychiatric complications are indeed common in hypothyroidism. Postoperative studies demonstrate that hypothyroid patients more commonly had neuropsychiatric complications (38% versus 18%, p<0.02) compared to control patients 3. Myxedema coma itself presents with altered mentation ranging from lethargy to coma 4.
Statement C - Myxedema Coma Life-Threatening (CORRECT)
Myxedema coma is unequivocally life-threatening 5. It represents the most severe presentation of hypothyroidism, marked by altered mentation, hypothermia, and hypoventilation 4. It can cause hypercapnic respiratory failure requiring intubation and mechanical ventilation 4. Prompt recognition and treatment with thyroid hormone replacement are essential to improve outcomes 4.
Statement D - Levothyroxine and Cardiac Disease (CORRECT)
This statement is accurate and represents an important clinical caveat. The guidelines specifically recommend endocrinology consultation for hypothyroid patients with cardiac disease 1. While hypothyroidism itself causes cardiovascular complications including diastolic dysfunction, pericardial effusion, and hypertension 6, initiating or increasing levothyroxine in patients with pre-existing coronary artery disease requires careful titration to avoid exacerbating angina or precipitating cardiac events. Patients below age 65 without cardiac risk factors can receive full replacement doses initially, but those with cardiac disease require gradual dose escalation 6.
Key Clinical Pitfalls
- Never dismiss hypothyroidism in pregnancy as "normal" - it requires immediate treatment and close monitoring with TSH checks every 4 weeks during the first half of pregnancy 1
- Levothyroxine requirements typically increase during pregnancy in women already on treatment 2
- Target TSH in pregnancy: <3 mIU/L in second trimester, <3.5 mIU/L in third trimester 1
- The blunted febrile response in hypothyroid patients can mask serious infections - maintain high clinical suspicion 3